Vireo Growth Inc. Completes Acquisition of M3 Wellness, a Nevada Dispensary
Vireo Growth closed the $500,000 acquisition of Nevada dispensary M3 Wellness using a mix of cash and newly issued shares.
Rhea-AI Summary
Vireo Growth (VREOD) has closed its previously announced indirect acquisition of M3 Wellness, a dispensary in Hawthorne, Nevada, under an asset purchase agreement dated June 5, 2026.
The total transaction consideration was $500,000, with $290,000 paid in cash at closing. The remaining $210,000 was satisfied through the issuance of 13,888 subordinate voting shares of Vireo at a deemed issue price of $15.12 per share.
Positive
- Completed acquisition of M3 Wellness Nevada dispensary for total consideration of $500,000
- Cash component of the M3 Wellness transaction limited to $290,000 at closing
Negative
- Equity portion of consideration involves issuance of 13,888 new subordinate voting shares
- Non-cash consideration of $210,000 increases share count at a deemed price of $15.12
Key Figures
- Total consideration
- $500,000
- M3 Wellness acquisition
- Cash consideration
- $290,000
- Settled at closing
- Share-settled consideration
- $210,000
- Balance satisfied through share issuance
- Shares issued
- 13,888 subordinate voting shares
- Issued for the acquisition balance
- Deemed issue price
- $15.12 per share
- Price assigned to shares issued in the transaction
Previous Acquisition Reports
-
Completed another dispensary acquisition using cash, note, and share issuance
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
asset purchase agreement financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), today announced the closing of its previously announced indirect acquisition of M3 Wellness, a dispensary located in Hawthorne, Nevada, from M3 Wellness, LLC (“M3 Wellness”) pursuant to an asset purchase agreement entered on June 5, 2026 (the “Transaction”).
The total consideration for the Transaction was
About Vireo Growth Inc.
Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) is a leading vertically integrated cannabis company building a broad platform across cannabis and adjacent agricultural markets. The Company operates cultivation, manufacturing, retail dispensaries, home delivery, distribution, and agricultural supply businesses across the United States, creating exposure to both cannabis and complementary adjacent markets. With operations in 10 states and more than 170 dispensaries nationwide, Vireo combines disciplined capital allocation, strategic acquisitions, and local market execution to scale its platform and drive long-term shareholder value. The Company is focused on expanding market share and strengthening its portfolio of consumer brands and services, while supporting the customers, employees, shareholders, and communities it serves. For more information about Vireo, visit www.vireogrowth.com.
Forward-Looking Information
This press release contains “forward-looking information” or “forward-looking statements” within the meaning of applicable United States and Canadian securities legislation (referred to herein as “forward-looking information”). Forward-looking information contained in this press release may be identified by the use of words such as “should,” “believe,” “estimate,” “would,” “looking forward,” “may,” “continue,” “expect,” “expected,” “will,” “likely,” “subject to,” and variations of such words and phrases, or any statements or clauses containing verbs in any future tense and includes statements regarding expectations around the Transaction and the expected benefits thereof. These statements should not be read as guarantees of future performance or results. Forward-looking information includes both known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company or its subsidiaries to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements or information contained in this press release and are, without limitation, based on the assumptions and subject to various risks as set out herein and in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q filed with the U.S. Securities Exchange Commission. Forward-looking information is based upon a number of estimates and assumptions of management, believed but not certain to be reasonable, in light of management’s experience and perception of trends, current conditions, and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment, and the availability of licenses, approvals and permits.
Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, the reader should not place undue reliance on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to: risks and uncertainties associated with the Transaction, some of which are beyond the Company’s control; the Company’s ability to maintain relationships with suppliers, customers, employees and other third parties as a result of the Transaction; the effects of the Transaction on the Company and the interests of various constituents; the nature, cost, impact and outcome of pending and future litigation, other legal or regulatory proceedings, or governmental investigations and actions; risks related to the timing and content of adult-use legislation in markets where the Company currently operates; current and future market conditions, including the market price of the subordinate voting shares of the Company; risks related to epidemics and pandemics; federal, state, local, and foreign government laws, rules, and regulations, including federal and state laws and regulations in the United States relating to cannabis operations in the United States and any changes to such laws or regulations; operational, regulatory and other risks; execution of business strategy; management of growth; difficulties inherent in forecasting future events; conflicts of interest; risks inherent in an agricultural business; risks inherent in a manufacturing business; liquidity and the ability of the Company to raise additional financing to continue as a going concern; the Company’s ability to meet the demand for flower in its various markets; our ability to dispose of our assets held for sale at an acceptable price or at all; and risk factors set out in the Company’s Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, which are available on EDGAR with the U.S. Securities and Exchange Commission at www.sec.gov and filed with the Canadian securities regulators and available under the Company’s profile on SEDAR+ at www.sedarplus.com.
The statements in this press release are made as of the date of this release. Except as required by law, we undertake no obligation to update any forward-looking statements or forward-looking information to reflect events or circumstances after the date of such statements.
Contact Information:
Lynn Ricci
Director Investor Relations & Corporate Communications
investor@vireogrowth.com
(781) 956-7052
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.